Skip Nav Destination
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
Issue Archive
January 8 2009
In this Issue
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
A biomarker panel for acute graft-versus-host disease
Sophie Paczesny,Oleg I. Krijanovski,Thomas M. Braun,Sung W. Choi,Shawn G. Clouthier,Rork Kuick,David E. Misek,Kenneth R. Cooke,Carrie L. Kitko,Angela Weyand,Daniel Bickley,Dawn Jones,Joel Whitfield,Pavan Reddy,John E. Levine,Samir M. Hanash,James L. M. Ferrara
PERSPECTIVE
REVIEW ARTICLES
CLINICAL TRIALS AND OBSERVATIONS
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia
Clinical Trials & Observations
Susan M. O'Brien,David F. Claxton,Michael Crump,Stefan Faderl,Thomas Kipps,Michael J. Keating,Jean Viallet,Bruce D. Cheson
HEMATOPOIESIS AND STEM CELLS
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements
Hong-Yan Du,Elena Pumbo,Jennifer Ivanovich,Ping An,Richard T. Maziarz,Ulrike M. Reiss,Deborah Chirnomas,Akiko Shimamura,Adrianna Vlachos,Jeffrey M. Lipton,Rakesh K. Goyal,Frederick Goldman,David B. Wilson,Philip J. Mason,Monica Bessler
IMMUNOBIOLOGY
Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function
Ramon Urrea Moreno,Juana Gil,Carmen Rodriguez-Sainz,Elena Cela,Victor LaFay,Brian Oloizia,Andrew B. Herr,Janos Sumegi,Michael B. Jordan,Kimberly A. Risma
LYMPHOID NEOPLASIA
Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia
Anastasia Hadzidimitriou,Nikos Darzentas,Fiona Murray,Tanja Smilevska,Eleni Arvaniti,Cristina Tresoldi,Athanasios Tsaftaris,Nikolaos Laoutaris,Achilles Anagnostopoulos,Frederic Davi,Paolo Ghia,Richard Rosenquist,Kostas Stamatopoulos,Chrysoula Belessi
MYELOID NEOPLASIA
Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia
Anne Saumet,Guillaume Vetter,Manuella Bouttier,Elodie Portales-Casamar,Wyeth W. Wasserman,Thomas Maurin,Bernard Mari,Pascal Barbry,Laurent Vallar,Evelyne Friederich,Khalil Arar,Bruno Cassinat,Christine Chomienne,Charles-Henri Lecellier
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses
Nirupama D. Verma,Karren M. Plain,Masaru Nomura,Giang T. Tran,Catherine Robinson,Rochelle Boyd,Suzanne J. Hodgkinson,Bruce M. Hall
VASCULAR BIOLOGY
CORRESPONDENCE
-
Cover Image
Cover Image
cPLA2α and integrin αllbβ3 reinforce each other's functions. Shown here are platelets from cPLA2α+/+ (top panel) and cPLA2α-/- (bottom panel) mice after plating on fibrinogen in the presence of a GP VI agonist, collagen-related peptide. Platelets were stained with an anti-phosphotyrosine antibody (green) and rhodamine-phalloidin (F-actin, red). Note the reduced spreading of cPLA2α platelets. See Figure 4 in the article by Prévost et al on page 447.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals